Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Cone-rod Dystrophy Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031

  • RnM4628636
    • |
  • 26 September, 2025
    • |
  • Global
    • |
  • 109 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Cone-rod Dystrophy Treatment market size was valued at US$ 26.8 million in 2024 and is forecast to a readjusted size of USD 273 million by 2031 with a CAGR of 24.0% during review period.
Cone dystrophy is an eye disease involving the cones, which are specialized structures in the eye used for color vision. Multiple forms of cone dystrophy have been discovered, and the condition is hereditary in nature. Treatment options focus on helping patients compensate for their vision loss.
The cone-rod dystrophy treatment market is driven by the increasing awareness of genetic retinal diseases and the rising number of patients diagnosed with cone-rod dystrophy (CRD). As CRD leads to progressive vision loss, especially in the central visual field, the demand for effective therapies to slow down or halt the progression of the disease is growing. Advances in genetic research and clinical trials focusing on gene therapies, retinal implants, and other innovative treatments are expected to offer promising solutions for CRD patients. Additionally, the increasing investment in ophthalmology research, as well as improved diagnostic techniques, are contributing to the market’s growth by enabling earlier diagnosis and intervention. As awareness of retinal degenerative diseases rises globally, the focus on providing better treatment options for rare eye conditions like CRD has intensified, attracting investment from both pharmaceutical companies and research institutions.
However, the market faces significant challenges, primarily due to the rarity of cone-rod dystrophy, which limits the overall patient population and slows down the development and commercialization of targeted treatments. The high costs associated with advanced therapies, particularly gene therapy and retinal prosthetics, may also restrict access for patients, especially in lower-income regions. Furthermore, despite the promising progress in treatment options, CRD is a complex disease with various genetic mutations, making the development of a universal treatment difficult. Regulatory approval processes for gene therapies and retinal treatments are long and complicated, adding to the timeline and cost of bringing new treatments to market. Additionally, there remains a need for more extensive clinical data to establish the long-term efficacy and safety of emerging therapies, which could further delay adoption.
Global Cone-rod Dystrophy Treatment includes JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, etc. North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific.
This report is a detailed and comprehensive analysis for global Cone-rod Dystrophy Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Cone-rod Dystrophy Treatment market size and forecasts, in consumption value ($ Million), 2020-2031
Global Cone-rod Dystrophy Treatment market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Cone-rod Dystrophy Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Cone-rod Dystrophy Treatment market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cone-rod Dystrophy Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cone-rod Dystrophy Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include JCyte, Nanoscope Therapeutics, SparingVision, MeiraGTx, AGTC, Biogen, Second Sight Medical, GlaxoSmithKline, Johnson And Johnson, Sanofi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Cone-rod Dystrophy Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Gene Therapy
Stem Cell Therapy
Retinal Implant Surgery
Market segment by Application
Hospital
Ophthalmology Department
Other
Market segment by players, this report covers
JCyte
Nanoscope Therapeutics
SparingVision
MeiraGTx
AGTC
Biogen
Second Sight Medical
GlaxoSmithKline
Johnson And Johnson
Sanofi
Pfizer
Novartis
Abbott Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Cone-rod Dystrophy Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cone-rod Dystrophy Treatment, with revenue, gross margin, and global market share of Cone-rod Dystrophy Treatment from 2020 to 2025.
Chapter 3, the Cone-rod Dystrophy Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Cone-rod Dystrophy Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cone-rod Dystrophy Treatment.
Chapter 13, to describe Cone-rod Dystrophy Treatment research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cone-rod Dystrophy Treatment by Type
    • 1.3.1 Overview: Global Cone-rod Dystrophy Treatment Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Cone-rod Dystrophy Treatment Consumption Value Market Share by Type in 2024
    • 1.3.3 Gene Therapy
    • 1.3.4 Stem Cell Therapy
    • 1.3.5 Retinal Implant Surgery
  • 1.4 Global Cone-rod Dystrophy Treatment Market by Application
    • 1.4.1 Overview: Global Cone-rod Dystrophy Treatment Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospital
    • 1.4.3 Ophthalmology Department
    • 1.4.4 Other
  • 1.5 Global Cone-rod Dystrophy Treatment Market Size & Forecast
  • 1.6 Global Cone-rod Dystrophy Treatment Market Size and Forecast by Region
    • 1.6.1 Global Cone-rod Dystrophy Treatment Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Cone-rod Dystrophy Treatment Market Size by Region, (2020-2031)
    • 1.6.3 North America Cone-rod Dystrophy Treatment Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Cone-rod Dystrophy Treatment Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Cone-rod Dystrophy Treatment Market Size and Prospect (2020-2031)
    • 1.6.6 South America Cone-rod Dystrophy Treatment Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Cone-rod Dystrophy Treatment Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 JCyte
    • 2.1.1 JCyte Details
    • 2.1.2 JCyte Major Business
    • 2.1.3 JCyte Cone-rod Dystrophy Treatment Product and Solutions
    • 2.1.4 JCyte Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 JCyte Recent Developments and Future Plans
  • 2.2 Nanoscope Therapeutics
    • 2.2.1 Nanoscope Therapeutics Details
    • 2.2.2 Nanoscope Therapeutics Major Business
    • 2.2.3 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Product and Solutions
    • 2.2.4 Nanoscope Therapeutics Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Nanoscope Therapeutics Recent Developments and Future Plans
  • 2.3 SparingVision
    • 2.3.1 SparingVision Details
    • 2.3.2 SparingVision Major Business
    • 2.3.3 SparingVision Cone-rod Dystrophy Treatment Product and Solutions
    • 2.3.4 SparingVision Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 SparingVision Recent Developments and Future Plans
  • 2.4 MeiraGTx
    • 2.4.1 MeiraGTx Details
    • 2.4.2 MeiraGTx Major Business
    • 2.4.3 MeiraGTx Cone-rod Dystrophy Treatment Product and Solutions
    • 2.4.4 MeiraGTx Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 MeiraGTx Recent Developments and Future Plans
  • 2.5 AGTC
    • 2.5.1 AGTC Details
    • 2.5.2 AGTC Major Business
    • 2.5.3 AGTC Cone-rod Dystrophy Treatment Product and Solutions
    • 2.5.4 AGTC Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 AGTC Recent Developments and Future Plans
  • 2.6 Biogen
    • 2.6.1 Biogen Details
    • 2.6.2 Biogen Major Business
    • 2.6.3 Biogen Cone-rod Dystrophy Treatment Product and Solutions
    • 2.6.4 Biogen Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Biogen Recent Developments and Future Plans
  • 2.7 Second Sight Medical
    • 2.7.1 Second Sight Medical Details
    • 2.7.2 Second Sight Medical Major Business
    • 2.7.3 Second Sight Medical Cone-rod Dystrophy Treatment Product and Solutions
    • 2.7.4 Second Sight Medical Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Second Sight Medical Recent Developments and Future Plans
  • 2.8 GlaxoSmithKline
    • 2.8.1 GlaxoSmithKline Details
    • 2.8.2 GlaxoSmithKline Major Business
    • 2.8.3 GlaxoSmithKline Cone-rod Dystrophy Treatment Product and Solutions
    • 2.8.4 GlaxoSmithKline Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 GlaxoSmithKline Recent Developments and Future Plans
  • 2.9 Johnson And Johnson
    • 2.9.1 Johnson And Johnson Details
    • 2.9.2 Johnson And Johnson Major Business
    • 2.9.3 Johnson And Johnson Cone-rod Dystrophy Treatment Product and Solutions
    • 2.9.4 Johnson And Johnson Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Johnson And Johnson Recent Developments and Future Plans
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Cone-rod Dystrophy Treatment Product and Solutions
    • 2.10.4 Sanofi Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Sanofi Recent Developments and Future Plans
  • 2.11 Pfizer
    • 2.11.1 Pfizer Details
    • 2.11.2 Pfizer Major Business
    • 2.11.3 Pfizer Cone-rod Dystrophy Treatment Product and Solutions
    • 2.11.4 Pfizer Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Pfizer Recent Developments and Future Plans
  • 2.12 Novartis
    • 2.12.1 Novartis Details
    • 2.12.2 Novartis Major Business
    • 2.12.3 Novartis Cone-rod Dystrophy Treatment Product and Solutions
    • 2.12.4 Novartis Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Novartis Recent Developments and Future Plans
  • 2.13 Abbott Laboratories
    • 2.13.1 Abbott Laboratories Details
    • 2.13.2 Abbott Laboratories Major Business
    • 2.13.3 Abbott Laboratories Cone-rod Dystrophy Treatment Product and Solutions
    • 2.13.4 Abbott Laboratories Cone-rod Dystrophy Treatment Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Abbott Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cone-rod Dystrophy Treatment Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Cone-rod Dystrophy Treatment by Company Revenue
    • 3.2.2 Top 3 Cone-rod Dystrophy Treatment Players Market Share in 2024
    • 3.2.3 Top 6 Cone-rod Dystrophy Treatment Players Market Share in 2024
  • 3.3 Cone-rod Dystrophy Treatment Market: Overall Company Footprint Analysis
    • 3.3.1 Cone-rod Dystrophy Treatment Market: Region Footprint
    • 3.3.2 Cone-rod Dystrophy Treatment Market: Company Product Type Footprint
    • 3.3.3 Cone-rod Dystrophy Treatment Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cone-rod Dystrophy Treatment Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Cone-rod Dystrophy Treatment Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Cone-rod Dystrophy Treatment Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Cone-rod Dystrophy Treatment Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Cone-rod Dystrophy Treatment Consumption Value by Type (2020-2031)
  • 6.2 North America Cone-rod Dystrophy Treatment Market Size by Application (2020-2031)
  • 6.3 North America Cone-rod Dystrophy Treatment Market Size by Country
    • 6.3.1 North America Cone-rod Dystrophy Treatment Consumption Value by Country (2020-2031)
    • 6.3.2 United States Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Cone-rod Dystrophy Treatment Consumption Value by Type (2020-2031)
  • 7.2 Europe Cone-rod Dystrophy Treatment Consumption Value by Application (2020-2031)
  • 7.3 Europe Cone-rod Dystrophy Treatment Market Size by Country
    • 7.3.1 Europe Cone-rod Dystrophy Treatment Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 7.3.3 France Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cone-rod Dystrophy Treatment Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Cone-rod Dystrophy Treatment Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Cone-rod Dystrophy Treatment Market Size by Region
    • 8.3.1 Asia-Pacific Cone-rod Dystrophy Treatment Consumption Value by Region (2020-2031)
    • 8.3.2 China Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 8.3.5 India Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Cone-rod Dystrophy Treatment Consumption Value by Type (2020-2031)
  • 9.2 South America Cone-rod Dystrophy Treatment Consumption Value by Application (2020-2031)
  • 9.3 South America Cone-rod Dystrophy Treatment Market Size by Country
    • 9.3.1 South America Cone-rod Dystrophy Treatment Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cone-rod Dystrophy Treatment Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Cone-rod Dystrophy Treatment Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Cone-rod Dystrophy Treatment Market Size by Country
    • 10.3.1 Middle East & Africa Cone-rod Dystrophy Treatment Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Cone-rod Dystrophy Treatment Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Cone-rod Dystrophy Treatment Market Drivers
  • 11.2 Cone-rod Dystrophy Treatment Market Restraints
  • 11.3 Cone-rod Dystrophy Treatment Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cone-rod Dystrophy Treatment Industry Chain
  • 12.2 Cone-rod Dystrophy Treatment Upstream Analysis
  • 12.3 Cone-rod Dystrophy Treatment Midstream Analysis
  • 12.4 Cone-rod Dystrophy Treatment Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Cone-rod Dystrophy Treatment. Industry analysis & Market Report on Cone-rod Dystrophy Treatment is a syndicated market report, published as Global Cone-rod Dystrophy Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Cone-rod Dystrophy Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo